Login to Your Account

Financings Roundup

Synageva Seeks $78M to Advance Orphan Drugs Pipe

By Marie Powers
Staff Writer

Friday, January 6, 2012

Synageva BioPharma Corp. priced its underwritten public offering of common stock, seeking to raise $78.3 million by selling 3,108,057 shares at $25.18 per share.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription